CFDI's Global Drug Inspection Trend Study Offers Regulatory Updates and Opinions

Posted 15 February 2017 By Yingying Liu, Siegfried Schmitt

placeholder+image To help keep regulatory professionals up-to-date on current thinking by global regulatory agencies, the Chinese Center of Food and Drug Inspection (CFDI) released a new electronic journal covering hot topics and developments in international drug manufacturing inspections. This article summarizes the key points including regulatory thinking and opinions from global regulatory authorities and organizations; timely updates on regulations, guidance, regulatory measures and changes; and inspection case analysis through observations by various international regulatory authorities.

Share this article:

Categories: Government affairs, Regulatory intelligence, Features, China, FDA, CFDA, WHO

Tags: Chinese Center of Food and Drug Inspection, CFDI

Regulatory Exchange: Latest Updates From the Community